(Q61981254)
Statements
Phase 3 Study of the Effects of Buprenophine as Add-on Treatment to Antidepressants in Treating Acutely Suicidal Depressed Inpatients (English)
0 references
November 2007
0 references
40
0 references
18 year
0 references
60 year
0 references